NRIIX vs. GBMFX
Compare and contrast key facts about Nuveen Real Asset Income Fund (NRIIX) and GMO Benchmark-Free Allocation Fund (GBMFX).
NRIIX is managed by Nuveen. It was launched on Sep 12, 2011. GBMFX is managed by GMO. It was launched on Jul 22, 2003.
Performance
NRIIX vs. GBMFX - Performance Comparison
Loading graphics...
NRIIX vs. GBMFX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NRIIX Nuveen Real Asset Income Fund | 2.36% | 12.55% | 7.56% | 10.38% | -11.50% | 10.58% | -3.45% | 22.74% | -6.10% | 12.39% |
GBMFX GMO Benchmark-Free Allocation Fund | 5.61% | 22.89% | 4.33% | 13.46% | -2.24% | 2.97% | -2.50% | 11.62% | -5.36% | 13.05% |
Returns By Period
In the year-to-date period, NRIIX achieves a 2.36% return, which is significantly lower than GBMFX's 5.61% return. Over the past 10 years, NRIIX has underperformed GBMFX with an annualized return of 5.84%, while GBMFX has yielded a comparatively higher 6.41% annualized return.
NRIIX
- 1D
- 0.92%
- 1M
- -3.72%
- YTD
- 2.36%
- 6M
- 3.41%
- 1Y
- 11.07%
- 3Y*
- 10.16%
- 5Y*
- 5.35%
- 10Y*
- 5.84%
GBMFX
- 1D
- 1.07%
- 1M
- -3.00%
- YTD
- 5.61%
- 6M
- 11.79%
- 1Y
- 23.90%
- 3Y*
- 14.40%
- 5Y*
- 8.00%
- 10Y*
- 6.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NRIIX vs. GBMFX - Expense Ratio Comparison
NRIIX has a 0.91% expense ratio, which is higher than GBMFX's 0.74% expense ratio.
Return for Risk
NRIIX vs. GBMFX — Risk / Return Rank
NRIIX
GBMFX
NRIIX vs. GBMFX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuveen Real Asset Income Fund (NRIIX) and GMO Benchmark-Free Allocation Fund (GBMFX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NRIIX | GBMFX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.64 | 3.02 | -1.38 |
Sortino ratioReturn per unit of downside risk | 2.16 | 4.00 | -1.84 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.61 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | 2.07 | 3.91 | -1.84 |
Martin ratioReturn relative to average drawdown | 9.00 | 15.09 | -6.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NRIIX | GBMFX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.64 | 3.02 | -1.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.64 | 1.11 | -0.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.81 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 0.96 | -0.22 |
Correlation
The correlation between NRIIX and GBMFX is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
NRIIX vs. GBMFX - Dividend Comparison
NRIIX's dividend yield for the trailing twelve months is around 6.32%, more than GBMFX's 3.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRIIX Nuveen Real Asset Income Fund | 6.32% | 6.71% | 5.39% | 6.70% | 5.81% | 4.34% | 4.63% | 5.99% | 5.82% | 5.73% | 5.47% | 5.70% |
GBMFX GMO Benchmark-Free Allocation Fund | 3.94% | 4.16% | 5.14% | 5.64% | 3.20% | 2.46% | 3.73% | 3.35% | 3.67% | 2.39% | 1.60% | 2.10% |
Drawdowns
NRIIX vs. GBMFX - Drawdown Comparison
The maximum NRIIX drawdown since its inception was -37.35%, which is greater than GBMFX's maximum drawdown of -23.40%. Use the drawdown chart below to compare losses from any high point for NRIIX and GBMFX.
Loading graphics...
Drawdown Indicators
| NRIIX | GBMFX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.35% | -23.40% | -13.95% |
Max Drawdown (1Y)Largest decline over 1 year | -5.74% | -5.98% | +0.24% |
Max Drawdown (5Y)Largest decline over 5 years | -18.44% | -14.42% | -4.02% |
Max Drawdown (10Y)Largest decline over 10 years | -37.35% | -23.40% | -13.95% |
Current DrawdownCurrent decline from peak | -3.84% | -3.64% | -0.20% |
Average DrawdownAverage peak-to-trough decline | -3.68% | -3.29% | -0.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.32% | 1.57% | -0.25% |
Volatility
NRIIX vs. GBMFX - Volatility Comparison
The current volatility for Nuveen Real Asset Income Fund (NRIIX) is 2.57%, while GMO Benchmark-Free Allocation Fund (GBMFX) has a volatility of 3.44%. This indicates that NRIIX experiences smaller price fluctuations and is considered to be less risky than GBMFX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NRIIX | GBMFX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.57% | 3.44% | -0.87% |
Volatility (6M)Calculated over the trailing 6-month period | 4.11% | 5.30% | -1.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 6.98% | 7.97% | -0.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 8.37% | 7.22% | +1.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 10.21% | 7.97% | +2.24% |